Your browser doesn't support javascript.
loading
A meta-analysis of the safety and effectiveness of pemetrexed compared with gefitinib for pre-treated advanced or metastatic NSCLC.
Lu, Xiaoxin; Li, Shengshu; Chen, Weizong; Zheng, Dongyang; Li, Yuzhu; Li, Fang.
Afiliação
  • Lu X; Department of Oncology.
  • Li S; Department of Pulmonary & Critical Care Medicine, Hainan Hospital of PLA General Hospital, Sanya.
  • Chen W; Xinglong Red Cross Hospital of Wanninng, Wanning City, Hainan Province, China.
  • Zheng D; Department of Pulmonary & Critical Care Medicine, Hainan Hospital of PLA General Hospital, Sanya.
  • Li Y; Department of Pulmonary & Critical Care Medicine, Hainan Hospital of PLA General Hospital, Sanya.
  • Li F; Department of Oncology.
Medicine (Baltimore) ; 99(29): e21170, 2020 Jul 17.
Article em En | MEDLINE | ID: mdl-32702875
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Pemetrexede / Gefitinibe Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Pemetrexede / Gefitinibe Idioma: En Ano de publicação: 2020 Tipo de documento: Article